Roundhill GLP-1 & Weight Loss ETF
OZEM
#3135
ETF rank
NZ$96.21 M
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
NZ$52.58
Share price
-2.02%
Change (1 day)
-8.26%
Change (1 year)
Roundhill GLP-1 & Weight Loss ETF (OZEM) provides exposure to companies developing innovative GLP-1 and other weight loss therapies.

Roundhill GLP-1 & Weight Loss ETF - Holdings

Etf holdings as of November 19, 2026Number of holdings: 24

Full holdings list

Weight %NameTickerISINShares Held
20.25%
Eli Lilly & CoLLYUS53245710838083
10.81%
Novo Nordisk A/SNVOUS6701002056149897
7.36%
Chugai Pharmaceutical Co Ltd4519 JPJP351940000087300
6.77%
Hanmi Pharm Co Ltd128940 KSKR712894000411503
5.78%
Pfizer IncPFEUS7170811035113197
5.02%
CSPC Pharmaceutical Group Ltd1093 HKHK10930121722560000
4.54%
Kailera Therapeutics IncKLRAUS4829311020211629
4.07%
Jiangsu Hengrui Pharmaceuticals Co Ltd1276 HKCNE100006XS6380200
3.79%
Hansoh Pharmaceutical Group Co Ltd3692 HKKYG549581067494000
3.72%
Viking Therapeutics IncVKTXUS92686J106077574
3.36%
Ascletis Pharma Inc1672 HKKYG0520K10943227000
3.26%
AstraZeneca PLCAZNGB000989529210026
2.98%
Amgen IncAMGNUS03116210093689
2.91%
Zealand Pharma A/SZEAL DCDK006025781450254
2.82%
Roche Holding AGROP SWCH14990599833213
2.70%
Structure Therapeutics IncGPCRUS86366E106485120
2.07%
United Laboratories International Holdings Ltd/The3933 HKKYG8813K10851222000
2.01%
Gubra A/SGUBRA DCDK006226647427580
1.92%
Innovent Biologics Inc1801 HKKYG4818G101095000
1.78%
MBX Biosciences IncMBXUS55287L101718003
1.47%
Gilead Sciences IncGILDUS37555810364756
0.74%
First American Government Obligations Fund 12/01/2031FGXXX398085.19
0.33%
Cash & OtherCash&Other179750.62
-0.47%
SWISS FRANCCHF-215321.29